Skip to main content

Advertisement

SpringerLink
Log in

Diagnostic value of prostate-specific antigen (PSA) and free prostate specific antigen (fPSA) in women with ovulatory and anovulatory polycystic ovary syndrome

  • Original Paper
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Diagnosis of polycystic ovary syndrome (PCOS) is very difficult in women with ovulatory cycles. We assessed the diagnostic value of prostate-specific antigen (PSA) and free prostate-specific antigen (fPSA) in women with ovulatory or anovulatory PCOS. Study group consisted of 62 women with PCOS and 35 healthy female controls. PCOS group was divided into two subgroups as anovulatory (n = 42; 68%, Group A) and ovulatory group (n = 20; 32%, Group B). A cut-off level of PSA and fPSA was established for the sensitivity, specificity, positive likelihood ratio, area under curve, diagnostic accuracy, and positive and negative predictive values of diagnosis of PCOS. In group A, a PSA level of greater than 10 pg/ml yielded a sensitivity of 73.2%, a specificity of 80%, and a diagnostic accuracy of 73%, with a positive predictive value of 88.2% and a negative predictive value of 59.3%. An fPSA level of greater than 2.1 pg/ml yielded a sensitivity of 71.2%, a specificity of 80.4%, and a diagnostic accuracy of 87%, with a positive predictive value of 87.2% and a negative predictive value of 58.4%. In group B, a PSA level of greater than 10 pg/ml yielded a sensitivity of 65%, a specificity of 80%, and a diagnostic accuracy of 73%, with a positive predictive value of 76.5% and a negative predictive value of 69.6%. An fPSA level of greater than 2.1 pg/ml yielded a sensitivity of 65.4%, a specificity of 80.4%, and a diagnostic accuracy of 87%, with a positive predictive value of 75.5% and a negative predictive value of 68.4%. Circulating androgens and hirsutism are independently associated with the degrees of PSA and fPSA in PCOS women. Increased plasma levels of PSA (>10 pg/ml) and fPSA (>2.1 pg/ml) could be helpful as a diagnostic tool for women with ovulatory or anovulatory PCOS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. J.S. Laven, B. Imani, M.J. Eijkemans, B.C. Fauser, Obstet.Gynecol.Surv 57, 755–767 (2003)

    Article  Google Scholar 

  2. J. Adams, D.W. Polson, S. Franks, Br.Med.J.(Clin.Res.Ed) 293, 355–359 (1986)

    Article  CAS  Google Scholar 

  3. E. Carmina, R.A. Lobo, Am.J.Med 111, 602–606 (2001)

    Article  CAS  PubMed  Google Scholar 

  4. S. Franks, Clin.Endocrinol.(Oxf) 31, 87–120 (1989)

    Article  CAS  Google Scholar 

  5. M. Asuncion, R.M. Calvo, J.L. San Millan, J. Sancho, S. Avila, H.F. Escobar-Morreale, J.Clin.Endocrinol.Metab 85, 2434–2438 (2000)

    Article  CAS  PubMed  Google Scholar 

  6. A.H. Balen, G.S. Conway, G. Kaltsas, K. Techatrasak, P.J. Manning, C. West, H.S. Jacobs, Hum.Reprod 10, 2107–2111 (1995)

    CAS  PubMed  Google Scholar 

  7. E.S. Knochenhauer, T.J. Key, M. Kahsar-Miller, W. Waggoner, L.R. Boots, R. Azziz, J.Clin.Endocrinol.Metab 83, 3078–3082 (1998)

    Article  CAS  PubMed  Google Scholar 

  8. M. Pugeat, M.H. Nicolas, J.C. Craves, C. varado-Dubost, S. Fimbel, H. Dechaud, H. Lejeune, Ann.N.Y.Acad.Sci 687, 124–135 (1993)

    Article  CAS  PubMed  Google Scholar 

  9. A. Vermeulen, L. Verdonck, J.M. Kaufman, J.Clin.Endocrinol.Metab 84, 3666–3672 (1999)

    Article  CAS  PubMed  Google Scholar 

  10. D. Cibula, M. Hill, L. Starka, Eur.J.Endocrinol 143, 405–408 (2000)

    Article  CAS  PubMed  Google Scholar 

  11. R.T. McCormack, H.G. Rittenhouse, J.A. Finlay, R.L. Sokoloff, T.J. Wang, R.L. Wolfert, H. Lilja, J.E. Oesterling, Urology 45, 729–744 (1995)

    Article  CAS  PubMed  Google Scholar 

  12. M.C. Wang, L.A. Valenzuela, G.P. Murphy, T.M. Chu, Invest Urol 17, 159–163 (1979)

    CAS  PubMed  Google Scholar 

  13. E.P. Diamandis, H. Yu, J.Clin.Endocrinol.Metab 80, 1515–1517 (1995)

    Article  CAS  PubMed  Google Scholar 

  14. H. Yu, E.P. Diamandis, D.J. Sutherland, Clin.Biochem 27, 75–79 (1994)

    Article  CAS  PubMed  Google Scholar 

  15. D.N. Melegos, H. Yu, M. Ashok, C. Wang, F. Stanczyk, E.P. Diamandis, J.Clin.Endocrinol.Metab 82, 777–780 (1997)

    Article  CAS  PubMed  Google Scholar 

  16. H. Yu, H. Berkel, J.La State Med.Soc 151, 209–213 (1999)

    CAS  PubMed  Google Scholar 

  17. S. Gullu, R. Emral, M. Asik, M. Cesur, V. Tonyukuk, J.Endocrinol.Invest 26, 1198–1202 (2003)

    CAS  PubMed  Google Scholar 

  18. C. Negri, F. Tosi, R. Dorizzi, A. Fortunato, G.G. Spiazzi, M. Muggeo, R. Castello, P. Moghetti, J.Clin.Endocrinol.Metab 85, 81–84 (2000)

    Article  CAS  PubMed  Google Scholar 

  19. C.V. Obiezu, A. Scorilas, A. Magklara, M.H. Thornton, C.Y. Wang, F.Z. Stanczyk, E.P. Diamandis, J.Clin.Endocrinol.Metab 86, 1558–1561 (2001)

    Article  CAS  PubMed  Google Scholar 

  20. D. Ferrıman, J.D. Gallwey, J.Clin.Endocrinol.Metab 1961(21), 1440–1447 (1961)

    Article  Google Scholar 

  21. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum.Reprod. 19, 41–47 (2004)

  22. M. Bahceci, M. Bilge, A. Tuzcu, S. Tuzcu, S. Bahceci, J.Endocrinol.Invest 27, 353–356 (2004)

    CAS  PubMed  Google Scholar 

  23. H. Yu, E.P. Diamandis, N. Zarghami, L. Grass, Breast Cancer Res.Treat 32, 291–300 (1994)

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology and Metabolism, Karadeniz Technical University, Trabzon, TURKEY

    Kubilay ÜKİNÇ, Halil Onder Ersoz, Cihangir Erem & Arif Bayram Hacihasanoglu

  2. Canakkale Onsekiz Mart Universitesi Tip Fakultesi Ic Hastaliklari ABD, Endokrinoloji ve Metabolizma Hastalıkları BD, 17100, Çanakkale, Turkey

    Kubilay ÜKİNÇ

Authors
  1. Kubilay ÜKİNÇ
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Halil Onder Ersoz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cihangir Erem
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arif Bayram Hacihasanoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kubilay ÜKİNÇ.

Rights and permissions

Reprints and permissions

About this article

Cite this article

ÜKİNÇ, K., Ersoz, H.O., Erem, C. et al. Diagnostic value of prostate-specific antigen (PSA) and free prostate specific antigen (fPSA) in women with ovulatory and anovulatory polycystic ovary syndrome. Endocr 35, 123–129 (2009). https://doi.org/10.1007/s12020-008-9130-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-008-9130-6

Keywords

Search

Navigation